Lupin Limited is a transnational pharmaceutical company based in Mumbai. It is the 2nd largest Indian pharma company by market capitalization;the 14th largest generic pharmaceutical company globally and; the 5th largest generic pharmaceutical company in the US by prescription-led market share. It has the distinction of being the fastest growing generic pharmaceutical player in the two largest pharmaceutical markets of the world ? the US and Japan; and is the 5th largest and the fastest growing generic pharmaceutical company History and Evolution Lupin was founded in 1968 by Dr. Desh Bandhu Gupta then an Associate Professor atA case study on lupin limited BITS-Pilani Rajasthan. Lupin first gained recognition when it became one of the world?s largest manufacturers of tuberculosis drugs. The company today has a significant market share in key markets in the Cardiovascular (prils and statins) Diabetology Asthma Pediatrics CNS GI Anti-Infectives and NSAIDs therapy segments. It also has a global leadership position in the Anti-TB and Cephalosporin segments. The company?s R&D endeavours have resulted in significant progress in its NCE program. Lupin?s foray into Advanced Drug Delivery Systems has resulted in the development of platform technologies that are being used to develop value-added generic pharmaceuticals. Its manufacturing facilities spread across India and Japan have played a critical role in enabling the company realizes its global aspirations. Benchmarked to International standards these facilities are approved by international regulatory agencies including the US FDA UK MHRA Japan?s MHLW TGA Australia WHO and the MCC South Africa.”
Our group of high quality writers are ready to help you with a similar paper within a specified deadline. Just click ORDER NOW and provide us with your assignment details, contact information and make payments. You will get periodic updates on order progress in your email.
USE THE CALCULATOR BELOW TO GET THE QUOTE